Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Study of Iguratimod in Patients With Active Rheumatoid Arthritis (RA)

NCT01554917 is registered in ClinicalTrials.gov with Jiangsu Simcere Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01554917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01554917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Study of Iguratimod in Patients With Active Rheumatoid Arthritis (RA)
Lead sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2012
Completion date
August 31, 2015
Enrollment
1,759 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis